US 7906628
Targeting proteins to deliver therapeutic or diagnostic reagents
granted A61KA61K38/00A61K47/66
Quick answer
US patent 7906628 (Targeting proteins to deliver therapeutic or diagnostic reagents) held by The Board of Regents of the University of Texas System expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Mar 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K38/00, A61K47/66, A61P, A61P35/00